This review concluded that resistance exercises for rheumatoid arthritis were safe and significantly improved muscle strength, disability, and functional capacity. The review process was generally good, but limitations to the trial quality and size suggest that the authors' conclusions should be considered to be tentative.
Study selection
Randomised controlled trials (RCTs) of resistance exercise in adults diagnosed with rheumatoid arthritis, as defined by the American Rheumatism Association (ARA) or ACR criteria, were eligible for inclusion. Trials of rehabilitation after surgery were excluded. Resistance exercises were defined as repetitive exercises, specifically designed to increase muscle strength through increased or adjusted resistance. The control group had to received non-aerobic rehabilitation, defined as static, range of motion, isometric, seated immersion, relaxation, stretching, no attention, or usual care; trials with aerobic exercise controls were excluded. Relevant outcomes were tender joint counts, pain and disability. The safety of the interventions was assessed by withdrawals and adverse events. Trials were excluded if they did not report extractable data.
Exercises were supervised in half the studies. Exercise programmes were targeted at different parts of the body. Where reported, sessions lasted from 15 to 60 minutes, ranging from daily to three times per week, for three to 104 weeks. The control groups received usual care, motion exercises, or non-aerobic exercise. The outcomes included: muscle strength; disability level, assessed by the Health Assessment Questionnaire (HAQ); functional capacity; disease activity level; swollen and tender joint count; pain on a visual analogue scale (VAS); the erythrocyte sedimentation rate, measured at one hour; exercise tolerance; and radiological damage. Mean age ranged from 41.4 to 62 years. Only 20% of trials specifically included early rheumatoid arthritis patients; in the other trials, disease had been diagnosed from 0.8 to 16.3 years in intervention groups and from 0.7 to 12.3 years in control groups.
Two independent reviewers selected studies, with disagreements resolved by discussion and with a third reviewer if necessary.
Assessment of study quality
Two independent reviewers assessed quality, using the Jadad scale, to give a score out of five for randomisation, blinding and withdrawals. Disagreements were resolved by discussion and with the help of a third reviewer if needed.
Data extraction
Two independent reviewers extracted the data, with disagreements resolved by discussion, including a third reviewer if necessary. Mean differences with 95% confidence intervals were calculated, for each group.
For most outcomes, the mean scores after the intervention were compared between groups. For the HAQ and muscle strength, the changes from baseline values were also compared. Where median values were reported, the median was used as the mean. Standard deviations were estimated conservatively if not reported. Inter-reviewer reliability was
